- Current Status of PSMA‑Targeted Radioligand Therapy in the Era of Radiopharmaceutical Therapy Acquiring Marketing Authorization
-
Oh S, Suh M, Cheon G
- KMID: 2537086
- Nucl Med Mol Imaging.
- 2022 Dec;56(6):263-281.
- doi: 10.1007/s13139-022-00764-4
Prostate-specific membrane antigen (PSMA) is highly expressed in PCa, which gradually increases in high-grade tumors, metastatic tumors, and tumors nonresponsive to androgen deprivation therapy. PSMA has been a topic of... -
- CITED
-
- Close
- SHARE
-
- Close
- A Negative Correlation Between Blood Glucose Level and 68Ga‑DOTA‑TOC Uptake in the Pancreas Uncinate Process
-
Oh D, Choi H, Paeng J, Kang K, Cheon G
- KMID: 2526705
- Nucl Med Mol Imaging.
- 2022 Feb;56(1):52-58.
- doi: 10.1007/s13139-021-00723-5
Purpose 68Ga-DOTA-TOC uptake in the pancreas uncinate process is often found due to physiologic expression of somatostatin receptors (SSTR). We investigated the association of physiologic 68Ga-DOTA-TOC uptake in the pancreas... -
- CITED
-
- Close
- SHARE
-
- Close
- Voxel‑Based Internal Dosimetry for 177 Lu‑Labeled Radiopharmaceutical Therapy Using Deep Residual Learning
-
Kim K, Lee M, Suh M, Cheon G, Lee J
- KMID: 2541620
- Nucl Med Mol Imaging.
- 2023 Apr;57(2):94-102.
- doi: 10.1007/s13139-022-00769-z
Purpose In this study, we propose a deep learning (DL)–based voxel-based dosimetry method in which dose maps acquired using the multiple voxel S-value (VSV) approach were used for residual learning. Methods... -
- CITED
-
- Close
- SHARE
-
- Close
- High-Dose Thoracic Re-irradiation of Lung Cancer Using Highly Conformal Radiotherapy Is Effective with Acceptable Toxicity
-
Hong JH, Kim YS, Lee SW, Lee SJ, Kang JH, Hong SH, Hong JY, Cheon G
- KMID: 2454307
- Cancer Res Treat.
- 2019 Jul;51(3):1156-1166.
- doi: 10.4143/crt.2018.472
PURPOSE: Thoracic re-irradiation (re-RT) of lung cancer has been challenged by the tolerance doses of normal tissues. We retrospectively analyzed local control, overall survival (OS) and toxicity after thoracic re-RT... -
- CITED
-
- Close
- SHARE
-
- Close
